Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR CORP | 8,188,770 7.600% |
-2,128,637 (-20.63%) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
The Vanguard Group | 8,838,240 8.250% |
115,792 (+1.33%) |
Filing History |
| 2024-02-09 6:19 pm Sale |
2024-02-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 5,194,729 4.800% |
-1,121,090 (-17.75%) |
Filing History |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR CORP | 10,317,407 9.630% |
-779,577 (-7.03%) |
Filing History |
| 2024-01-25 4:59 pm Sale |
2023-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
BLACKROCK INC BLK |
8,629,707 8.100% |
-537,110 (-5.86%) |
Filing History |
| 2024-01-25 11:11 am Unchanged |
2023-12-29 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
J P MORGAN CHASE & CO JPM |
7,219,436 6.700% |
0 (Unchanged) |
Filing History |
| 2024-01-25 11:10 am Purchase |
2023-12-29 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
J P MORGAN CHASE & CO JPM |
7,219,436 6.700% |
1,118,392 (+18.33%) |
Filing History |
| 2023-09-27 4:05 pm Sale |
2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX |
REGENERON PHARMACEUTICALS INC REGN |
100 100.000% |
-2,097,214 (-100.00%) |
Filing History |
| 2023-08-18 5:16 pm Unchanged |
2023-08-08 | 13D | Decibel Therapeutics, Inc. DBTX |
REGENERON PHARMACEUTICALS INC REGN |
2,097,314 8.300% |
0 (Unchanged) |
Filing History |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 6,315,819 5.900% |
923,949 (+17.14%) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR CORP | 11,096,984 10.362% |
287,238 (+2.66%) |
Filing History |
| 2023-02-09 11:30 am Purchase |
2022-12-30 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
The Vanguard Group | 8,722,448 8.150% |
563,933 (+6.91%) |
Filing History |
| 2023-02-03 4:27 pm Sale |
2022-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
BLACKROCK INC BLK |
9,166,817 8.600% |
-444,054 (-4.62%) |
Filing History |
| 2023-01-11 12:09 pm Purchase |
2022-12-30 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
J P MORGAN CHASE & CO JPM |
6,101,044 5.600% |
6,101,044 (New Position) |
Filing History |
| 2022-10-11 09:03 am Purchase |
2022-10-07 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
FMR CORP | 10,809,746 10.084% |
746,781 (+7.42%) |
Filing History |
| 2022-02-11 4:07 pm Purchase |
2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
REGENERON PHARMACEUTICALS INC REGN |
180,910 1.840% |
180,910 (New Position) |
Filing History |
| 2022-02-11 4:06 pm Purchase |
2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
REGENERON PHARMACEUTICALS INC REGN |
3,702,995 4.980% |
925,218 (+33.31%) |
Filing History |
| 2022-02-11 4:05 pm Purchase |
2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
REGENERON PHARMACEUTICALS INC REGN |
2,097,314 8.420% |
2,097,314 (New Position) |
Filing History |
| 2022-02-11 2:48 pm Sale |
2022-02-14 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
Capital World Investors | 5,391,870 5.100% |
-1,625,252 (-23.16%) |
Filing History |
| 2022-02-10 08:32 am Purchase |
2021-12-31 | 13G | Regeneron Pharmaceuticals, Inc. REGN |
The Vanguard Group | 8,158,515 7.720% |
227,295 (+2.87%) |
Filing History |